首页|西地兰在心力衰竭时的干预效果分析

西地兰在心力衰竭时的干预效果分析

扫码查看
目的 探究在心力衰竭治疗与护理干预时,使用西地兰治疗的效果.方法 针对40例心力衰竭患者使用常规方法干预,并归为对照组,针对另外40例患者在对照组干预的基础上使用西地兰,并归为观察组,2组患者均为本院2015年3月~2017年1月间收治.结果比较2组患者有效率发现,观察组患者明显较高,其中观察者患者为92.5%,对照组患者为72.5%;2组患者的心率、血压在治疗前均无明显差异,经过分组干预后观察组患者改善明显较佳,差异具有统计学意义(P<0.05).2组患者均无明显不良反应.结论 西地兰在心力衰竭治疗与干预效果分析发现,能够改善患者临床情况,提高临床治疗效果,且无明显的不良反应,值得临床借鉴.
The effect analysis of cedilanid in heart failure
Objective To explore the treatment and nursing intervention in heart failure, the use of cedilanid therapy. Methods In 40 cases of heart failure patients using conventional methods of intervention, and classified as the control group, the other 40 patients in the control group using Western intervention on LAN, and classified as the observation group, two groups the patients in our hospital from January 2017 to March 2015. Results The two groups of patients have found efficiency, patients in the observation group were significantly higher, the observation of patients was 92.5%, the control group was 72.5%; the two groups of patients with heart rate, blood pressure were not significantly different in the treatment before and after intervention in observation group were improved after grouping obviously better than that shows obvious differences (P<0.05). The two groups had no obvious adverse reactions. Conclusion Cediland analysis shows that in the treatment of heart failure and intervention effect, can improve the clinical situation of patients, improve the clinical treatment effect, and no significant adverse reactions, worthy of clinical reference.

cedilanidheart failurenursing intervention

吴亚华、沈华

展开 >

湖州市练市人民医院 内科,浙江 湖州 313013

西地兰 心力衰竭 护理干预

2017

中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
年,卷(期):2017.37(8)
  • 3
  • 4